President And Cofounder
Current• Developed the first FDA-authorized (Class II) at-home immersive virtual reality (VR) pain treatment indicated as an adjunct treatment for chronic lower back pain (cLBP).• Total funds raised to date of $80+ million, including key investors F-Prime Capital, JAZZ Venture Partners, Silicon Valley Bank, Sway Ventures, GSR Ventures, Magnetic Ventures and Cedars-Sinai• Secured Breakthrough Device Designation by FDA for RelieVRx -- the first virtual reality (VR) digital therapeutic to get breakthrough designation -- for treatment of conditions related to chronic pain• 2021 and 2022 Fast Company Most Innovative Company in the augmented and virtual reality category• Inaugural cohort for Techstars / Cedars-Sinai healthcare accelerator • Featured in Wired, Forbes, New York Times, Mashable and MIT Technology Review and as speaker at international conferences such as South by Southwest, Partners Connected Health and Virtual Medicine. About AppliedVR:AppliedVR is creating a new reality in healthcare. We are pioneering immersive therapeutics (ITx), a new category of medicine, to treat intractable health conditions that affect millions of people worldwide. Today, AppliedVR's treatments represent a robust approach to chronic lower back pain (CLBP) that empowers patients with an intuitive device they can self-manage at home. AppliedVR's RelieVRx® program is the first VR-based, prescription therapeutic to receive Breakthrough Device Designation and De Novo authorization by the FDA for CLBP.
